Mesoblast | MSB - Ordinary Share Capital


Mesoblast reported $1.29B in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Clinuvel Pharmaceuticals AUD 50.2M 77.11K Dec/2025
Cochlear AUD 65.4M 1.12B Dec/2025
CSL USD 482.13M 93.87M Dec/2025
Pacific Edge NZD 1.02B 497K Jun/2026
Paradigm Biopharmaceuticals AUD 428.52M 39.09M Dec/2025
PYC Therapeutics AUD 597.24M 366.66M Dec/2025
Ramsay Health Care AUD 229.93M 29.81K Dec/2025
Sonic Healthcare AUD 4.15B 467K Dec/2024
Starpharma Holdings AUD 419.92M 179.17M Dec/2025
Telix Pharmaceuticals AUD 338.78M 379K Dec/2025